Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein
- PMID: 1427370
- PMCID: PMC1379484
- DOI: 10.1136/gut.33.9.1190
Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein
Abstract
The eosinophil population is increased in the jejunal mucosa of patients with coeliac disease. Eosinophils may participate in the mucosal damage by releasing their granule components that have cytotoxic properties such as eosinophil cationic protein (ECP) and major basic protein (MBP). This study aimed to assess the presence of ECP and MBP in the jejunal mucosa of 10 adult patients with active coeliac disease who presented with villous flattening. Endoscopic jejunal biopsy specimens were obtained from macroscopically flattened jejunal mucosa and were processed for ultrastructural study and immunogold labelling using anti-MBP, anti-ECP, and anti-IgA antibodies. Numerous eosinophils were found in the upper part of the lamina propria and showed two types of morphological change: some were lytic and others exhibited ultrastructural signs of activation, containing altered granules with fading of the central core. IgA plasma cells were intermingled with eosinophils and had dense deposits on the external side of their cytoplasmic membrane. MBP was detected in central cores of granules but also diffusely in their matrix and in tight association with dense extracellular deposits. Conversely, ECP was detected only in the matrix of eosinophil granules. This study showed that numerous eosinophils are in an activated state in the mucosa of patients with active coeliac disease and release cytotoxic proteins such as MBP, which could contribute to the mucosal damage. The observation that eosinophils and IgA plasmocytes were closely associated in the mucosa supports a role for IgA in eosinophil recruitment and activation in coeliac disease.
Similar articles
-
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.Am J Med. 1989 Jan;86(1):56-64. doi: 10.1016/0002-9343(89)90230-1. Am J Med. 1989. PMID: 2535919
-
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.Clin Exp Immunol. 1988 Dec;74(3):404-8. Clin Exp Immunol. 1988. PMID: 3233790 Free PMC article.
-
Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease.Gastroenterology. 1992 Jul;103(1):137-45. doi: 10.1016/0016-5085(92)91106-e. Gastroenterology. 1992. PMID: 1612323
-
Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.Dig Dis Sci. 1996 Feb;41(2):282-8. doi: 10.1007/BF02093816. Dig Dis Sci. 1996. PMID: 8601370 Review.
-
Selectivity of mediators released by eosinophils.Int Arch Allergy Appl Immunol. 1989;88(1-2):54-8. doi: 10.1159/000234748. Int Arch Allergy Appl Immunol. 1989. PMID: 2523359 Review.
Cited by
-
Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects With IgE-Mediated Peanut Allergy.Front Immunol. 2018 Nov 22;9:2624. doi: 10.3389/fimmu.2018.02624. eCollection 2018. Front Immunol. 2018. PMID: 30524424 Free PMC article. Clinical Trial.
-
Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia.Dig Dis Sci. 2008 Oct;53(10):2634-40. doi: 10.1007/s10620-008-0207-0. Epub 2008 Mar 5. Dig Dis Sci. 2008. PMID: 18320315
-
Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.Gut. 1995 Aug;37(2):242-6. doi: 10.1136/gut.37.2.242. Gut. 1995. PMID: 7557575 Free PMC article.
-
Intestinal eosinophils, homeostasis and response to bacterial intrusion.Semin Immunopathol. 2021 Jun;43(3):295-306. doi: 10.1007/s00281-021-00856-x. Epub 2021 Apr 30. Semin Immunopathol. 2021. PMID: 33929602 Free PMC article. Review.
-
Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.Front Immunol. 2020 Jul 8;11:1374. doi: 10.3389/fimmu.2020.01374. eCollection 2020. Front Immunol. 2020. PMID: 32733456 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous